PersonalEyes Canberra Optometry CPD evening
Date: 26/09/2025 (AEST)
Venue: Crown Plaza Canberra, ACT, 2601
Provider: PersonalEYES
Contact: Marcus Liew, [E] marcusl@personaleyes.com.au, [P] 02 6281 1688
Activity Outline
An evening with world class Ophthalmologists to update on the latest technology and studies in ophthalmology.
Learning Objectives
- Discuss the role of gene therapy in the potential future treatment of macula degeneration
- Recognise the role of topical drops and MiGS in the treatment of glaucoma.
- Distinguish the features of a myopic disc and a glaucomatous disc
Max CPD hours awarded: 3
Session Information
| Name |
|---|
| Gene therapy for wet AMD, is this the end of AntiVEGF injections for macular degeneration? |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1.0 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.0 |
| Name |
|---|
| Glaucoma drops and the role of MiGs |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1.0 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.0 |
| Name |
|---|
| Myopia or Glaucoma? + surgical cases |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1.0 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.0 |